Clinical Trial Update: The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether a GLP-1 receptor agonist affects cerebral blood flow velocity in non-stroke volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Christina Kruuse | Conditions: Stroke | Phase 2 | Status: COMPLETED